Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigraineRecruiting
NCT07018700Phase 3Updated Aug 21, 2026
Sponsor: Merz Therapeutics GmbH
Episodic Migraine
United States, Austria, Canada, Czechia, Denmark +8 more
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Recruiting
NCT07221253Phase 3Updated Aug 21, 2026
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightCompleted
NCT05929066Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Obesity · Overweight · Osteoarthritis, Knee · Obstructive Sleep Apnea
United States, Australia, Brazil, Canada, Hungary +7 more
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsRecruiting
NCT06499285Phase 3Updated Aug 21, 2026
Sponsor: Takeda
Myelodysplastic Syndromes
United States, Australia, Brazil, Bulgaria, Canada +21 more
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)Recruiting
NCT07210515Phase 3Updated Aug 21, 2026
Sponsor: Ambros Therapeutics, Inc.
Complex Regional Pain Syndrome Type I
United States
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRecruiting
NCT06655155Phase 2Updated Aug 21, 2026
Sponsor: argenx
Systemic Sclerosis (SSc)
United States, Argentina, Belgium, Bulgaria, Chile +19 more
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)Active Not Recruiting
NCT05639114Phase 3Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Bulgaria, Canada +14 more
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)Recruiting
NCT06430801Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT06226883Phase 2Updated Aug 21, 2026
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Inflammatory Bowel Diseases · Crohn's Disease
United States, Australia, Austria, Bosnia and Herzegovina, Brazil +23 more
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Recruiting
NCT07032662Phase 2Updated Aug 21, 2026
Sponsor: Immunovant Sciences GmbH
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Australia, Austria, Belgium +25 more
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Recruiting
NCT06623422Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +26 more
ATSN-201 Gene Therapy in RS1-Associated X-linked RetinoschisisRecruiting
NCT05878860Phase 3Updated Aug 21, 2026
Sponsor: Atsena Therapeutics Inc.
X-linked Retinoschisis
United States, United Kingdom
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia GravisRecruiting
NCT06414954Phase 2Updated Aug 21, 2026
Sponsor: NMD Pharma A/S
Myasthenia Gravis · Myasthenia Gravis, MuSK
United States, Belgium, Denmark, France, Georgia +5 more
4D-150 in Patients With Neovascular (Wet) Age-Related Macular DegenerationRecruiting
NCT05197270Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: 4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
United States, Puerto Rico
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseRecruiting
NCT06847321Phase 2Updated Aug 21, 2026
Sponsor: Lighthouse Pharmaceuticals, Inc.
Alzheimer Disease · Alzheimer Disease Due to P. Gingivalis
United States
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusRecruiting
NCT06617325Phase 3Updated Aug 21, 2026
Sponsor: UCB Biopharma SRL
Systemic Lupus Erythematosus
United States, Argentina, Belgium, Canada, Chile +17 more
A Phase 2/3 Study of Brepocitinib in Adults With Cutaneous SarcoidosisRecruiting
NCT06978725Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Priovant Therapeutics, Inc.
Cutaneous Sarcoidosis
United States
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Recruiting
NCT06077760Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +28 more
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With AchondroplasiaRecruiting
NCT07441876Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: BioMarin Pharmaceutical
Achondroplasia
United States, Australia, Canada, Italy, Japan +4 more
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive Not Recruiting
NCT04147494EARLY_Phase 1Updated Aug 21, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Breast Carcinoma · Colon Carcinoma · Esophageal Carcinoma · Gastric Carcinoma
United States
A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid TumorsActive Not Recruiting
NCT05593094Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Hoffmann-La Roche
Advanced Solid Tumors · HER2-positive Breast Cancer
United States, Australia, France, Italy, New Zealand +2 more
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarRecruiting
NCT07754461Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Type 2 Diabetes
United States, Australia, Canada, India, New Zealand +1 more
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting
NCT07392190Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Overweight · Obesity
United States, Australia, Belgium, Brazil, China +9 more
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Recruiting
NCT07174336Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Breast Neoplasms · Neoplasm Metastasis
United States, Argentina, Australia, Belgium, Brazil +14 more
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialRecruiting
NCT06432036Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Stage I Renal Cell Cancer · Stage II Renal Cell Cancer
United States

Previous page Next page